Tag: HIV prevention | Page 2

Preventing HIV during the COVID-19 pandemic: PEP and PIP to the rescue

April 19, 2021 • By Dr. Amila Heendeniya

HIV continues to be a global health threat, even amid the COVID-19 pandemic. In keeping with UNAIDS goals for reducing that burden, HIV prevention by PEP and PrEP have played major roles in reaching those goals. While PrEP has been instrumental in preventing HIV in people with high-risk exposures, we have seen gaps in HIV prevention strategies, especially among individuals who have less frequent exposures. This is where “pill-in-pocket PEP”, better known as PIP, has a substantial role to play.

The impact of ‘It’s a Sin’: Lessons from the U.K.

March 14, 2021 • By John McCullagh and Ian Green

To find out how the series It’s A Sin started a national dialogue about HIV in the United Kingdom, and what Canadian HIV organizations can learn from that experience, former CATIE board chair John McCullagh spoke to Ian Green, chief executive officer of Terrence Higgins Trust, the largest HIV charity in the United Kingdom.

Accessing PrEP: The PrEPStart program in Ontario

March 10, 2021 • By Nasra Smith

Over the past five years, Ontario has seen a steady increase in the number of people using pre-exposure prophylaxis (PrEP). Between January and March 2020, 8,413 people were on PrEP – up from 289 in 2015. While most of these people live larger cities like Toronto and Ottawa, PrEP use has also increased in regions across the province.

What do online users want from HIV/STI risk calculators?

January 11, 2021 • By Oralia Gómez-Ramírez and Hsiu-Ju Chang

Risk calculators for HIV and other sexually transmitted infections (STIs) use answers to a set of sociodemographic characteristics (e.g., age, sex, ethnicity, geographic location), health status, or behavioural questions to estimate a person’s risk for developing or acquiring HIV and STIs. They can also indicate the most appropriate action for users to take.

Re-imagining HIV prevention with young adult Black same-gender-loving men

October 7, 2020 • By David Absalom

Current HIV prevention efforts have and continue to fail Black same-gender-loving (SGL)* men. But with meaningful reflection and changes to service delivery, this can change.

Top HIV and hepatitis C stories of 2019

December 17, 2019 • By CATIE

In 2019, we saw significant developments in the prevention, diagnosis and treatment of HIV and hepatitis C. We helped launch a blueprint for hepatitis C elimination in Canada. We witnessed innovation in HIV prevention and testing approaches, more people cured of hepatitis C, and “the London patient”, the second person cleared of HIV after discontinuing antiretroviral therapy. We also saw drawbacks. We continue to confront a devastating opioid overdose crisis driven by a poisoned drug supply, which claimed the lives of more than 2,000 Canadians in the first six months of the year alone.